Ace Inhibitors



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 64.8%
Drug Use For Unknown Indication 13.9%
Hypertension 4.2%
Depression 2.4%
Arthralgia 1.8%
Hepatitis C 1.8%
Oedema Peripheral 1.8%
Ill-defined Disorder 1.2%
Pain 1.2%
Proteinuria 1.2%
Bronchitis 0.6%
Cardiovascular Disorder 0.6%
Diabetes Mellitus 0.6%
Diuretic Therapy 0.6%
Focal Segmental Glomerulosclerosis 0.6%
Multiple Myeloma 0.6%
Nephrotic Syndrome 0.6%
Oedema 0.6%
Renal Transplant 0.6%
Poisoning 21.4%
Completed Suicide 14.3%
Death 9.5%
Renal Impairment 7.1%
Thrombosis In Device 7.1%
Angioedema 4.8%
Renal Failure Acute 4.8%
Anaphylactic Reaction 2.4%
Cardiac Failure Congestive 2.4%
Colitis Ulcerative 2.4%
Depressed Level Of Consciousness 2.4%
Drug Abuse 2.4%
Drug Toxicity 2.4%
Hypothyroidism 2.4%
Multiple Drug Overdose Intentional 2.4%
Proteinuria 2.4%
Pruritus 2.4%
Psoriasis 2.4%
Skin Ulcer 2.4%
Swollen Tongue 2.4%
Concomitant
Product Used For Unknown Indication 27.4%
Hypertension 22.0%
Diabetes Mellitus 9.3%
Type 2 Diabetes Mellitus 8.0%
Dyslipidaemia 4.7%
Arteriosclerosis 4.2%
Schizophrenia 4.2%
Acute Myocardial Infarction 3.3%
Myocardial Infarction 2.6%
Hyperlipidaemia 2.6%
Cardiac Failure 1.8%
Percutaneous Coronary Intervention 1.6%
Hepatitis C 1.4%
Pain 1.4%
Osteoporosis 1.1%
Schizophrenia, Paranoid Type 1.1%
Anaesthesia 0.9%
Atrial Fibrillation 0.9%
Bipolar Disorder 0.8%
Cardiac Failure Chronic 0.8%
Weight Increased 47.4%
Pancreatitis 6.7%
Renal Failure Acute 3.8%
Renal Failure 3.3%
Vomiting 3.3%
Weight Decreased 3.3%
Cerebrovascular Accident 2.9%
Death 2.9%
Dyspnoea 2.9%
Neoplasm Malignant 2.9%
Arrhythmia 2.4%
Blood Glucose Increased 2.4%
Cardiac Failure 2.4%
Myocardial Ischaemia 2.4%
Renal Failure Chronic 2.4%
Thrombosis In Device 2.4%
Aortic Stenosis 1.9%
Anaemia 1.4%
Cardiac Failure Congestive 1.4%
Extrapyramidal Disorder 1.4%